Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 16,357 shares, a drop of 56.2% from the August 15th total of 37,364 shares. Approximately 1.4% of the shares of the company are short sold. Based on an average daily volume of 272,520 shares, the short-interest ratio is currently 0.1 days.

Analysts Set New Price Targets

ADVB has been the subject of a number of analyst reports. Wall Street Zen upgraded Advanced Biomed to a “hold” rating in a research note on Saturday, August 22nd. Weiss Ratings upgraded Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, July 23rd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Advanced Biomed presently has an average rating of “Sell”.

Advanced Biomed Stock Down 0.7%

NASDAQ ADVB traded down $0.06 on Monday, hitting $8.13. The stock had a trading volume of 9,296 shares, compared to its average volume of 850,294. The company’s 50-day moving average is $8.56 and its two-hundred day moving average is $6.14. Advanced Biomed has a one year low of $3.61 and a one year high of $24.23. The stock has a market cap of $13.41 million, a price-to-earnings ratio of 1.69 and a beta of -0.29.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.